Polar’s ASAC Journey: Rising Strong Five Months After the Storm

Polar, our 10-year-old Siberian husky, is a warrior with a wagging tail, battling anal sac adenocarcinoma (ASAC), a fierce cancer, with a spirit that refuses to dim. Five months ago, in December 2024, complacency let his tumors spiral, with swelling and bleeding we struggled to catch, pushing us to the edge of despair. Yet, Polar’s warm brown eyes still sparkle, and his latest vet visit (May 8, 2025) brought radiant hope: his ASAC tumor is shrinking, inflammation and bleeding tamed by ivermectin, a triumph rooted in Dr. Thomas Seyfried’s ketogenic diet research and Dr. William Makis’s protocol, started March 9, 2025, and fully launched March 30 after MDR1 gene clearance on March 29. Now, a new ally—DMSO—joins the fight, aiming to carry ivermectin deeper into Polar’s tumors, potentially blasting past the shrinkage plateau. Join our $POLAR memecoin community to share Polar’s story and cheer him on! #PolarInu #CanineCancer

Polar’s Progress
On May 8, 2025, Polar bounded into the vet’s office, his tail a joyful blur. At 23.8kg, he’s a touch lean but bright and alert, a world away from December 2024, when complacency let his tumors surge with swelling and bleeding we couldn’t catch in time. The vet’s news was a gift: Polar’s ASAC tumor, once raw, ulcerated, and bleeding, is shrinking, its 1cm ulcer healing beautifully. Secondary lumps from a biopsy are flattening, fading like whispers. A head cyst, removed in late February 2025, has healed well, leaving only a faint scar. We dream of a CT/MRI to check for metastasis, but it’s not possible yet. Polar dives into his K9 Natural ketogenic diet—60% fish, 40% pork—with pup-like gusto, his strength a bold stand against ASAC.

That December crisis taught us vigilance; times are different now, with ivermectin hammering inflammation and bleeding, a lifeline we lacked then. First noticed in May 2024 and diagnosed via biopsy in July 2024 with a 6–18-month prognosis, Polar’s at month 10, not just surviving but thriving—without surgery, chemo, or radiation. Early on, our vet noted concerns in session records about removing carbohydrates, Polar’s energy source, warning of risks as Polar was thin (25.4kg, August 2024). They dismissed fenbendazole, citing no evidence, but Dr. Thomas Seyfried’s research, which sparked our journey, shows ketogenic diets mirror the low-carb, high-fat ancestral diet of wolves, before domestication brought grains and rising cancer rates. Polar’s vibrant energy on his fish-and-pork diet echoes this wisdom, defying norms. We nearly rushed into surgery pre-diagnosis, driven by fear, but chose a path inspired by Seyfried and Makis, validated by this vet visit. This milestone shows Polar’s body is fighting back, a beacon of hope for others that unconventional paths can spark miracles. His playful bounds and gleaming eyes are a daily gift, and we’re cherishing every moment.

His vet-approved protocol, guided by Dr. Makis, includes:
Ivermectin: Originally 0.6ml/day oral (0.5mg/kg, March 30, 2025), adjusted to 0.36–0.48ml/day oral (0.3–0.4mg/kg, May 16, 2025) to avoid systemic overload with DMSO-enhanced topical paste, plus 1.87% topical paste (~0.3–0.5g twice daily, May 14, 2025).

Fenbendazole: Pulse dosing, now at higher confidential doses than the initial ~222–444mg/day, per Makis’s request, paused during February 2025 surgery, resumed March 2025 (May 8, 2025).

Baking Soda: ~½ tsp/day in food for alkaline balance and bowel health (May 8, 2025).

DMSO: ~0.3ml (50% solution) once daily to tumors, followed immediately by ivermectin paste, starting May 16, 2025, after my self-test (May 15, 2025).

Vet-Compounded Paste: ~1ml/day, applied topically, per Makis (May 14, 2025).

CBD Oil: 0.5mg/kg, monitoring liver enzymes (May 8, 2025).

Vitamin C: 1,000mg/day for bowel support (May 14, 2025).

Castor Oil: 2–3 drops for slow bowels (May 14, 2025).
All vet-guided, not medical advice. Polar’s weight is stable, his bowel issues are gone, and his joy lights up our days (May 14, 2025).

The Journey and New Steps
Polar’s journey is a tapestry of courage, blending ancient roots with modern defiance. Our research began with Dr. Thomas Seyfried, whose ketogenic diet and press-pulse therapy starved Polar’s cancer of glucose, starting in June 2024 before a diagnosis. A perianal lump, noticed in May 2024 and confirmed as an epithelial tumor in July 2024, led to a storm of choices. Our vet urged surgery and desexing, warning in session notes that delaying desexing could worsen the tumor due to testosterone and that low carbs risked Polar’s energy needs. They dismissed fenbendazole, citing no evidence, but Seyfried’s insights showed canines thrived on meat and fat before domestication brought grains and rising cancer rates. By December 2024, complacency let his tumors spiral, with swelling and bleeding we couldn’t catch, a heart-wrenching low that felt like the end. Polar’s spirit refused to fade.

Inspired by Dr. Makis, March 2025 turned the tide. On March 9, we began his interim protocol with fenbendazole (pulse dosing), ivermectin paste (topical, twice daily), and vet-compounded paste (topical, once daily), cautious of Polar’s MDR1 gene risks as a Siberian husky. After clearance on March 29, we launched the full protocol on March 30, adding oral ivermectin and increasing doses. The impact was swift: inflammation plummeted, bleeding subsided, and tumors began to retreat, as shared on X (@PolarInu_SOL, April 26, 2025). Five months later, the May 8 vet visit confirmed Polar’s thriving, with ivermectin’s “big hammer” anchoring stability we lacked in December.

Now, DMSO enters as a potential “plateau blaster,” carrying ivermectin deeper into Polar’s tumors, like a targeted therapy without needles. With inflammation down but tissue shrinkage slower, we’re fine-tuning its use: starting May 16, 2025, we’ll apply 0.3ml 50% DMSO once daily (morning) to Polar’s tumor sites, followed immediately by ~0.3–0.5g ivermectin paste to maximize penetration, after my self-test (May 15, 2025). Originally, Polar received ~0.6ml/day oral ivermectin (0.5mg/kg) plus ~0.3g topical paste twice daily (March 30, 2025), but to avoid systemic overload from DMSO’s enhanced topical absorption, we’ve lowered the oral dose to ~0.3–0.4mg/kg/day (7.14–9.52mg/day) while increasing topical paste to ~0.3–0.5g twice daily for targeted delivery. If tolerated after 1–2 weeks, we may add a second DMSO dose (evening), per vet guidance. This cautious, vet-guided step aims to push past ASAC’s resistance, with early signs possibly emerging in weeks. Polar’s playful spirit and bright eyes tell us we’re on track, and we’re savoring every second of his fight.

Join Polar’s Pack
Polar’s journey is a story of heart, resilience, and hope, and we’d love you to be part of it. Five months after a spiral born of complacency, Polar’s thriving, a husky hero showing what’s possible with love and paths that echo ancient wisdom. His warm brown eyes and wagging tail are a daily gift, and we’re honored to share his fight. Connect with our $POLAR memecoin community, launched April 14, 2025, on X (@PolarInu_SOL) to follow his updates. Share his story with #PolarInu #CanineCancer to spread his light.